\begin{table}[htbp]\centering\begin{tabular}{lccc}\hline
Characteristic & Train & Test & P-value \\
\hline
Number of patients & 1504 & 644 & \\

\makecell[l]{Outcome} & $232.83 \pm 401.48$ & $212.25 \pm 379.34$ & 0.269  \\

\makecell[l]{Gender} & 0: 83.5\%, 1: 16.5\% & 0: 81.2\%, 1: 18.8\% & 0.218  \\

\makecell[l]{First Visit Age} & $23.23 \pm 22.67$ & $21.84 \pm 21.03$ & 0.184  \\

\makecell[l]{CI nd U} & 0: 99.3\%, 1: 0.7\% & 0: 99.2\%, 1: 0.8\% & 1.000  \\

\makecell[l]{Lymphocytes Percentage \\ chronic} & $35.60 \pm 10.31$ & $35.92 \pm 10.10$ & 0.496  \\

\makecell[l]{Lymphocytes Percentage \\ preclinical} & $38.76 \pm 14.56$ & $38.58 \pm 15.06$ & 0.785  \\

\makecell[l]{Lymphocytes Percentage \\ acute} & $32.83 \pm 14.12$ & $33.20 \pm 14.25$ & 0.579  \\

\makecell[l]{Neutrophils Percentage \\ chronic} & $54.36 \pm 11.09$ & $53.91 \pm 11.02$ & 0.391  \\

\makecell[l]{Neutrophils Percentage \\ preclinical} & $50.56 \pm 16.07$ & $50.69 \pm 16.35$ & 0.862  \\

\makecell[l]{Neutrophils Percentage \\ acute} & $59.12 \pm 15.49$ & $58.60 \pm 15.79$ & 0.481  \\

\makecell[l]{Monocytes Percentage \\ preclinical} & $6.66 \pm 0.95$ & $6.73 \pm 1.07$ & 0.121  \\

\makecell[l]{Monocytes Percentage \\ chronic} & $6.53 \pm 0.97$ & $6.52 \pm 0.78$ & 0.791  \\

\makecell[l]{Monocytes Percentage \\ acute} & $6.22 \pm 1.06$ & $6.24 \pm 1.12$ & 0.636  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration chronic} & $333.85 \pm 6.42$ & $334.05 \pm 5.93$ & 0.478  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration acute} & $337.26 \pm 12.42$ & $337.06 \pm 10.64$ & 0.726  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration \\ preclinical} & $343.12 \pm 7.35$ & $343.74 \pm 6.38$ & 0.063  \\

\makecell[l]{Platelet Count chronic} & $255.71 \pm 43.50$ & $252.30 \pm 38.76$ & 0.086  \\

\makecell[l]{Platelet Count acute} & $258.59 \pm 64.53$ & $258.73 \pm 65.65$ & 0.963  \\

\makecell[l]{Platelet Count \\ preclinical} & $251.86 \pm 48.34$ & $255.61 \pm 51.96$ & 0.108  \\

\makecell[l]{White Blood Cell Count \\ acute} & $9.90 \pm 2.96$ & $10.12 \pm 3.12$ & 0.131  \\

\makecell[l]{White Blood Cell Count \\ preclinical} & $8.53 \pm 1.92$ & $8.57 \pm 1.76$ & 0.602  \\

\makecell[l]{White Blood Cell Count \\ chronic} & $8.55 \pm 1.52$ & $8.46 \pm 1.62$ & 0.251  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin preclinical} & $28.39 \pm 1.74$ & $28.42 \pm 1.59$ & 0.778  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin acute} & $28.63 \pm 2.03$ & $28.57 \pm 1.88$ & 0.512  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin chronic} & $28.90 \pm 1.57$ & $28.89 \pm 1.41$ & 0.902  \\

\makecell[l]{Mean Corpuscular Volume \\ acute} & $84.91 \pm 6.16$ & $84.79 \pm 6.01$ & 0.680  \\

\makecell[l]{Mean Corpuscular Volume \\ chronic} & $86.48 \pm 4.73$ & $86.37 \pm 4.35$ & 0.597  \\

\makecell[l]{Mean Corpuscular Volume \\ preclinical} & $82.92 \pm 5.74$ & $82.82 \pm 5.48$ & 0.704  \\

\makecell[l]{Hemoglobin preclinical} & $127.68 \pm 7.75$ & $128.15 \pm 6.77$ & 0.186  \\

\makecell[l]{Hemoglobin acute} & $129.27 \pm 8.96$ & $129.42 \pm 8.89$ & 0.726  \\

\makecell[l]{Hemoglobin chronic} & $130.00 \pm 5.97$ & $130.54 \pm 5.41$ & 0.046  \\

\makecell[l]{Eosinophils Percentage \\ acute} & $1.60 \pm 1.83$ & $1.62 \pm 2.00$ & 0.815  \\

\makecell[l]{Eosinophils Percentage \\ chronic} & $2.24 \pm 1.37$ & $2.31 \pm 1.62$ & 0.263  \\

\makecell[l]{Eosinophils Percentage \\ preclinical} & $2.72 \pm 2.66$ & $2.73 \pm 1.87$ & 0.942  \\

\makecell[l]{Basophils Percentage \\ preclinical} & $0.27 \pm 0.13$ & $0.27 \pm 0.14$ & 0.782  \\

\makecell[l]{Basophils Percentage \\ acute} & $0.21 \pm 0.17$ & $0.22 \pm 0.18$ & 0.157  \\

\makecell[l]{Basophils Percentage \\ chronic} & $0.30 \pm 0.16$ & $0.30 \pm 0.17$ & 0.480  \\

\makecell[l]{Absolute Eosinophil \\ Count preclinical} & $0.22 \pm 0.35$ & $0.22 \pm 0.18$ & 0.730  \\

\makecell[l]{Absolute Eosinophil \\ Count chronic} & $0.18 \pm 0.13$ & $0.18 \pm 0.14$ & 0.598  \\

\makecell[l]{Absolute Eosinophil \\ Count acute} & $0.14 \pm 0.16$ & $0.14 \pm 0.18$ & 0.689  \\

\makecell[l]{Absolute Lymphocyte \\ Count preclinical} & $3.19 \pm 1.31$ & $3.21 \pm 1.34$ & 0.739  \\

\makecell[l]{Absolute Lymphocyte \\ Count acute} & $2.95 \pm 1.24$ & $3.08 \pm 1.37$ & 0.036  \\

\makecell[l]{Absolute Lymphocyte \\ Count chronic} & $2.74 \pm 0.98$ & $2.71 \pm 0.87$ & 0.543  \\

\makecell[l]{Mean Platelet Volume \\ preclinical} & $9.54 \pm 0.80$ & $9.51 \pm 0.81$ & 0.352  \\

\makecell[l]{Mean Platelet Volume \\ chronic} & $9.10 \pm 0.99$ & $9.17 \pm 1.02$ & 0.159  \\

\makecell[l]{Mean Platelet Volume \\ acute} & $9.78 \pm 1.14$ & $9.77 \pm 1.11$ & 0.921  \\

\makecell[l]{Platelet Distribution \\ Width acute} & $11.99 \pm 1.99$ & $11.89 \pm 1.92$ & 0.266  \\

\makecell[l]{Platelet Distribution \\ Width preclinical} & $11.81 \pm 1.52$ & $11.88 \pm 1.53$ & 0.364  \\

\makecell[l]{Platelet Distribution \\ Width chronic} & $12.04 \pm 1.37$ & $12.14 \pm 1.48$ & 0.133  \\

\makecell[l]{Eosinophil Count \\ Absolute chronic} & $176.72 \pm 98.01$ & $182.97 \pm 129.72$ & 0.221  \\

\makecell[l]{Eosinophil Count \\ Absolute acute} & $123.65 \pm 122.92$ & $126.03 \pm 119.83$ & 0.678  \\

\makecell[l]{Eosinophil Count \\ Absolute preclinical} & $233.27 \pm 219.27$ & $228.03 \pm 145.87$ & 0.578  \\

\makecell[l]{CR eactive Protein \\ preclinical} & $8.78 \pm 6.86$ & $8.72 \pm 7.24$ & 0.861  \\

\makecell[l]{CR eactive Protein \\ acute} & $9.98 \pm 10.90$ & $9.95 \pm 11.48$ & 0.951  \\

\makecell[l]{CR eactive Protein \\ chronic} & $5.64 \pm 6.30$ & $5.67 \pm 5.38$ & 0.917  \\

\makecell[l]{Immunoglobulin E \\ chronic} & $206.99 \pm 157.45$ & $241.75 \pm 476.83$ & 0.012  \\

\makecell[l]{Immunoglobulin E acute} & $155.46 \pm 108.98$ & $150.03 \pm 100.14$ & 0.279  \\

\makecell[l]{Free Thyroxine chronic} & $16.14 \pm 0.87$ & $16.21 \pm 0.96$ & 0.104  \\

\makecell[l]{Free Thyroxine acute} & $15.36 \pm 0.76$ & $15.38 \pm 0.77$ & 0.460  \\

\makecell[l]{SMRNP acute} & $1.36 \pm 0.82$ & $1.31 \pm 0.56$ & 0.145  \\

\makecell[l]{SMRNP chronic} & $1.20 \pm 0.79$ & $1.22 \pm 0.59$ & 0.610  \\

\makecell[l]{Anti SSA chronic} & $1.36 \pm 3.16$ & $1.21 \pm 0.42$ & 0.228  \\

\makecell[l]{Anti SSA acute} & $1.15 \pm 3.62$ & $1.11 \pm 2.39$ & 0.770  \\

\makecell[l]{Anti Jo 1 chronic} & $1.07 \pm 0.91$ & $1.06 \pm 0.37$ & 0.845  \\

\makecell[l]{Anti Jo 1 acute} & $0.82 \pm 0.42$ & $0.82 \pm 0.44$ & 0.883  \\

\makecell[l]{Nucleosome acute} & $1.13 \pm 0.73$ & $1.16 \pm 0.75$ & 0.279  \\

\makecell[l]{Nucleosome chronic} & $0.53 \pm 0.44$ & $0.54 \pm 0.44$ & 0.727  \\

\makecell[l]{Ribosomal PP rotein \\ chronic} & $1.15 \pm 0.25$ & $1.31 \pm 3.43$ & 0.078  \\

\makecell[l]{Ribosomal PP rotein \\ acute} & $1.09 \pm 0.28$ & $1.07 \pm 0.27$ & 0.162  \\

\makecell[l]{Ro 52 acute} & $1.88 \pm 3.55$ & $1.73 \pm 0.39$ & 0.283  \\

\makecell[l]{Ro 52 chronic} & $1.88 \pm 3.00$ & $1.73 \pm 0.38$ & 0.223  \\
\hline\end{tabular}\caption{Comparison of the characteristics between the training and testing datasets in the time dependent dataset \\ continuous variables are presented as mean Â± standard deviation, categorical variables are presented as number (percentage)} \label{tab:train_test_time}
\end{table}